Vera Therapeutics Inc - Class A

NAS:VERA (USA)   Class A
$ 39.84 +1.15 (+2.97%) 03:30 PM EST
At Loss
P/B:
17.40
Volume:
420.00K
Avg Vol (2M):
1.05M
Volume:
420.00K
At Loss
Avg Vol (2M):
1.05M

Business Description

Vera Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US92337R1014

Share Class Description:

VERA: Class A
Description
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 2.99
Equity-to-Asset 0.58
Debt-to-Equity 0.53
Debt-to-EBITDA -0.58
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 45
3-Year EPS without NRI Growth Rate 43.6
3-Year FCF Growth Rate 36.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.38
9-Day RSI 41.14
14-Day RSI 43.84
6-1 Month Momentum % 316.38
12-1 Month Momentum % 550.55

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.71
Quick Ratio 7.71
Cash Ratio 7.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -29.5
Shareholder Yield % -6.16
Name Current Vs Industry Vs History
ROE % -79.92
ROA % -54.09
ROIC % -1427.22
ROC (Joel Greenblatt) % -2250.04
ROCE % -60.3